Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL IMMUNOLOGY
Volume 41, Issue 8, Pages 1733-1744
Publisher
Springer Science and Business Media LLC
Online
2021-09-27
DOI
10.1007/s10875-021-01136-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
- (2021) Nicolas de Prost et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients
- (2021) Rutger Koning et al. INTENSIVE CARE MEDICINE
- Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
- (2021) Jesús Troya et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
- (2021) Paul Bastard et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Diverse Functional Autoantibodies in Patients with COVID-19
- (2021) Eric Y. Wang et al. NATURE
- Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 infection
- (2021) Bo Diao et al. Nature Communications
- Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β
- (2021) Donald C. Vinh et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges
- (2020) Chih-Cheng Lai et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Immunology of COVID-19: current state of the science
- (2020) Nicolas Vabret et al. IMMUNITY
- Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence
- (2020) Lisheng Wang et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
- (2020) Jérôme Hadjadj et al. SCIENCE
- Beneficial Effect of Corticosteroids in Preventing Mortality in Patients Receiving Tocilizumab to Treat Severe COVID-19 Illness
- (2020) Manuel Rubio-Rivas et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Targeting acute kidney injury in COVID-19
- (2020) John A Kellum et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
- (2020) Andrew T. Levin et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started